These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 9671405)
1. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein. Vallian S; Gäken JA; Gingold EB; Kouzarides T; Chang KS; Farzaneh F Oncogene; 1998 Jun; 16(22):2843-53. PubMed ID: 9671405 [TBL] [Abstract][Full Text] [Related]
2. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Echlin DR; Tae HJ; Mitin N; Taparowsky EJ Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209 [TBL] [Abstract][Full Text] [Related]
3. Effects on differentiation by the promyelocytic leukemia PML/RARalpha protein depend on the fusion of the PML protein dimerization and RARalpha DNA binding domains. Grignani F; Testa U; Rogaia D; Ferrucci PF; Samoggia P; Pinto A; Aldinucci D; Gelmetti V; Fagioli M; Alcalay M; Seeler J; Grignani F; Nicoletti I; Peschle C; Pelicci PG EMBO J; 1996 Sep; 15(18):4949-58. PubMed ID: 8890168 [TBL] [Abstract][Full Text] [Related]
4. The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1. Doucas V; Brockes JP; Yaniv M; de Thé H; Dejean A Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9345-9. PubMed ID: 8415704 [TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Borden KL; Lally JM; Martin SR; O'Reilly NJ; Solomon E; Freemont PS Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1601-6. PubMed ID: 8643677 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of GATA-2 activity through interactions with the promyelocytic leukemia protein (PML) and the t(15;17)-generated PML-retinoic acid receptor alpha oncoprotein. Tsuzuki S; Towatari M; Saito H; Enver T Mol Cell Biol; 2000 Sep; 20(17):6276-86. PubMed ID: 10938104 [TBL] [Abstract][Full Text] [Related]
7. Colocalization and heteromerization between the two human oncogene POZ/zinc finger proteins, LAZ3 (BCL6) and PLZF. Dhordain P; Albagli O; Honore N; Guidez F; Lantoine D; Schmid M; The HD; Zelent A; Koken MH Oncogene; 2000 Dec; 19(54):6240-50. PubMed ID: 11175338 [TBL] [Abstract][Full Text] [Related]
8. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia. Tussié-Luna MI; Rozo L; Roy AL Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964 [TBL] [Abstract][Full Text] [Related]
9. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078 [TBL] [Abstract][Full Text] [Related]
10. PML/RARalpha plays a role for basal activity and retinoid-induced repression of the tissue factor promoter in acute promyelocytic leukemia cells. Tenno T; Oberg F; Mackman N; Nilsson K; Siegbahn A Thromb Haemost; 2003 Nov; 90(5):930-9. PubMed ID: 14597990 [TBL] [Abstract][Full Text] [Related]
12. Cooperation between the RING + B1-B2 and coiled-coil domains of PML is necessary for its effects on cell survival. Fagioli M; Alcalay M; Tomassoni L; Ferrucci PF; Mencarelli A; Riganelli D; Grignani F; Pozzan T; Nicoletti I; Grignani F; Pelicci PG Oncogene; 1998 Jun; 16(22):2905-13. PubMed ID: 9671411 [TBL] [Abstract][Full Text] [Related]
13. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene. Manna PR; Eubank DW; Stocco DM Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133 [TBL] [Abstract][Full Text] [Related]
15. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Suzukawa K; Colburn NH Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401 [TBL] [Abstract][Full Text] [Related]
16. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655 [TBL] [Abstract][Full Text] [Related]
17. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha. Duprez E; Lillehaug JR; Naoe T; Lanotte M Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787 [TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia protein PML inhibits Nur77-mediated transcription through specific functional interactions. Wu WS; Xu ZX; Ran R; Meng F; Chang KS Oncogene; 2002 May; 21(24):3925-33. PubMed ID: 12032831 [TBL] [Abstract][Full Text] [Related]
19. Ret finger protein is a normal component of PML nuclear bodies and interacts directly with PML. Cao T; Duprez E; Borden KL; Freemont PS; Etkin LD J Cell Sci; 1998 May; 111 ( Pt 10)():1319-29. PubMed ID: 9570750 [TBL] [Abstract][Full Text] [Related]
20. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells. Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]